FDA Investigator: Scott B. Laufenberg
- Scott B. Laufenberg first started conducting FDA inspections in 2002, with the last inspection in 2024. Over that time, Scott B. Laufenberg has conducted 335 inspections at 261 companies across 289 sites.
Get Scott Laufenberg's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Neuralink, Fremont | June 2023
Available Now - $199
Scott B. Laufenberg
Medical Devices & Rad Health Form 483
FDA 483 Quest Life Sciences Pvt., Ltd., Chennai | 2018
Out-of-stock
Scott B. Laufenberg
Human Drug Form 483
FDA 483 Notrox Research Private Limited, Salem | 2017
Out-of-stock
Scott B. Laufenberg
Human Drug Form 483
Co-Investigators (34)
- Terri E. Gibson, FDA Investigator
- Blankenship, D'Arbra R, FDA Investigator
- Kristin M. Abaonza, FDA Investigator
- Hugh M. McClure, FDA Investigator
- Jeanne J. Thai, FDA Investigator
- Lori Gioia, FDA Investigator
- Eileen J. Bannerman, FDA Investigator
- Annette Melendez, FDA Investigator
- Sandra S. Saniga, FDA Investigator
- Mural B. Gavini, FDA Investigator
- Susan M. Miller, FDA Investigator
- Corey K. Reno, FDA Investigator
- Peter T. Erlandson, FDA Investigator
- Aimee J. Edwin, FDA Investigator
- Tara M. Carolfi, FDA Investigator
- Michelle J. Glembin, FDA Investigator
- Justin J. Jafferis, FDA Investigator
- Karen M. Labounty, FDA Investigator
- Marie A. Fadden, FDA Investigator
- Justin A. Boyd, FDA Investigator
- Sharon L. Matson, FDA Investigator
- Peter R. Lenahan, FDA Investigator
- Joel Martinez, FDA Investigator
- Charles Cote, FDA Investigator
- Denise L. Burosh, FDA Investigator
- Jon C. Polzine, FDA Investigator
- Ronald R. Ruff, FDA Investigator
- Gregory W. Smith, FDA Investigator
- Aaron L. Dunbar, FDA Investigator
- Theresa C. Klaman, FDA Investigator
- Scott L. Schenian, FDA Investigator
- Mary-Ann Ruff, FDA Investigator
- Jeffery A. Hangartner, FDA Investigator
- Jeffry A. Bernhardt, FDA Investigator